Erelzi

Active Ingredient(s): Etanercept-szzs
FDA Approved: * August 30, 2016
Pharm Company: * SANDOZ INC
Category: Arthritis

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Erelzi Overview

Etanercept (trade name Enbrel or Benepali) is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis factor (TNF, a soluble inflammatory cytokine) by acting as a TNF inhibitor. It has U.S. F.D.A. approval to treat rheumatoid arthritis, juvenile idiopathic arthritis and psoriatic arthritis, plaque psoriasis and ankylosing spondylitis. TNF-alpha is the "master regulator" of the inflammatory (immune) response in many organ systems. Autoimmune diseases are caused b...

Read more Erelzi Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Etanercept

Recent Erelzi Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs: